[1
]Adult Mesenchymal Tumor and Rare Cancer Unit, Cancer Medicine Department, Fondazione
IRCCS Istituto Nazionale Tumori, Milan, Italy
[2
]The Royal Marsden Hospital and The Institute of Cancer Research, London, UK
[3
]Department of Radiology, The Royal Marsden Hospital and The Institute of Cancer Research,
London, UK
[4
]Radiology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
[5
]Palliative Care Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
[6
]Department of Pathology, Memorial Sloan Kettering Cancer Center and Weill Cornell
Medical College, New York, USA
[7
]Medical Oncology Department, Tata Memorial Centre, Homi Bhabha National Institute,
Mumbai, India
[8
]Department of Radiation Oncology, Dana-Farber Cancer Center/Brigham and Women's Hospital,
Boston, USA
[9
]Department of Medical Oncology, West German Cancer Center, Sarcoma Center, University
of Duisburg-Essen, University Hospital, Essen, Germany
[10
]Orthopaedic Department, Regina Elena National Cancer Institute, Rome, Italy
[11
]Klinikum Stuttgart – Olgahospital, Zentrum für Kinder-, Jugend- und Frauenmedizin,
Stuttgart Cancer Center, Pädiatrische Onkologie, Hämatologie, Immunologie, Stuttgart,
Germany
[12
]Department of Medical Oncology, Centre Leon Berard, Université Claude Bernard Lyon,
Unicancer, Lyon, France
[13
]Department of Surgical Oncology, Institut Curie, Université Paris Sciences et Lettres,
Paris, France
[14
]Nordix, Athens, Greece
[15
]Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
[16
]Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo,
Norway
[17
]Medical University Vienna & General Hospital Department of Internal Medicine 1/Oncology,
Vienna, Austria
[18
]Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
[19
]Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University
of Sevilla/CIBERONC, Seville, Spain
[20
]Department of Normal and Pathological Cytology and Histology, School of Medicine,
University of Seville, Seville, Spain
[21
]The EHE Foundation, Wisconsin, USA
[22
]Department of Oncology, Skane University Hospital and Lund University, Lund, Sweden
[23
]Orthopaedic Service, Musculoskeletal Oncology Department, IRCCS Istituto Ortopedico
Rizzoli, Bologna, Italy
[24
]Medical Oncology Division, P.A. Herzen Cancer Research Institute, Moscow, Russian
Federation
[25
]Sarcomas and Rare Tumors Unit, IRCCS Regina Elena National Cancer Institute, Rome,
Italy
[26
]Paediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
[27
]Department of Pathology Brigham & Women's Hospital, Boston, USA
[28
]University of Barcelona and Genitourinary Cancer and Sarcoma Unit Institut Català
d'Oncologia, Hospitalet, Barcelona, Spain
[29
]Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands
[30
]University of Toronto and Lunenfeld-Tanenbaum Research Institute, Toronto, Canada
[31
]Department of Surgery, Centre Leon Berard, Lyon, France
[32
]Division of Medical Oncology, Candiolo Cancer Institute, FPO – IRCCS, Candiolo, Italy
[33
]NUY Langone Medical Center, New York, USA
[34
]Department of Radiotherapy, the Netherlands Cancer Institute, Amsterdam, the Netherlands
[35
]Department of Radiotherapy, the Leiden University Medical Center, Leiden, the Netherlands
[36
]Group of Advanced Therapies and Biomarkers in Sarcoma, Institute of Biomedicine of
Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Seville, Spain
[37
]Division of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center,
University of Heidelberg, Heidelberg, Germany
[38
]Division of Molecular Pathology, The Institute of Cancer Research, London, UK
[39
]Department of Oncology, Helsinki University Hospital & Helsinki University, Helsinki,
Finland
[40
]Department of Cancer, The Royal Marsden Hospital and The Institute of Cancer Research,
London, UK
[41
]Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
[42
]University of Heidelberg, Mannheim University Medical Center, Sarcoma Unit, Mannheim,
Germany
[43
]Musculoskeletal Oncology and Rehabilitation Medicine, Rare Cancer Center National
Cancer Center Hospital, Tokyo, Japan
[44
]International Department, Gustave Roussy, Villejuif, France
[45
]UCLH - University College London Hospitals NHS Foundation Trust, London, UK
[46
]Department of Orthopaedics and Trauma Medical University Graz, Graz, Austria
[47
]Chair of Trustees of the EHE Rare Cancer Charity (UK), Charity number 1162472
[48
]Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona,
Spain
[49
]Hospital Universitario Fundación Jimenez Diaz, Madrid, Spain
[50
]Unit of Soft Tissue and Bone Oncology, Division of Oncology, Tel-Aviv Medical Center
affiliated with Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
[51
]Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
[52
]Department of Clinical Epidemiology and Trial Organisation, Fondazione IRCCS Istituto
Nazionale dei Tumori, Milan, Italy
[53
]Sarcoma Group, Gustave Roussy, Villejuif, France
[54
]University of Pittsburgh Medical Center, Thomas Starzl Transplant Institute, Pittsburgh,
USA
[55
]Oncology, CHUV Lausanne, Lausanne, Switzerland
[56
]Division of Abdominal Surgery, University Hospitals of Geneva, Geneva, Switzerland
[57
]Chemotherapy Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
[58
]Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna,
Italy
[59
]Sarcoma Center, The University of Texas M.D. Anderson Cancer Center, Houston, USA
[60
]Department of Medical Oncology, Institut Curie, Paris, France
[61
]Department of Surgery, Brigham and Women's Hospital, Boston, USA
[62
]Center for Sarcoma and Bone Oncology, Harvard Medical School, Boston, USA
[63
]Dana Farber Cancer Center, Harvard Medical School, Boston, USA
[64
]Princess Margaret Cancer Centre and Sinai Healthcare System & Faculty of Medicine,
University of Toronto, Toronto, Canada
[65
]Helios Klinikum Berlin-Buch, Department of Oncology and Palliative Care, Berlin, Germany
[66
]Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland,
USA
[67
]Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft
Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland
[68
]Aarhus University Hospital, Aarhus, Denmark
[69
]Department of Radiation Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan,
Italy
[70
]Multi-Organ Transplant and HPB Surgical Oncology, Division of General Surgery, Department
of Surgery, University of Toronto, Toronto, Canada
[71
]Department of Pathology, Azienda Ospedaliera Università Padova, Padua, Italy
[72
]Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria
[73
]Leuven Cancer Institute, Leuven, Belgium
[74
]Department of Surgery, The Royal Marsden Hospital and The Institute of Cancer Research,
London, UK
[75
]University College London Hospital, London, UK
[76
]Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical
College, New York, USA
[77
]Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale
Tumori, Milan, Italy
[78
]Palliative Care, The Royal Marsden Hospital and The Institute of Cancer Research London
[79
]Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
[80
]Department of Orthopedic Surgery Bone and Soft Tissue Tumor Unit, Leiden University
Medical Center, Leiden, The Netherlands
[81
]Sarcoma and Melanoma Unit, The Netherlands Cancer Institute, Amsterdam, The Netherlands
[82
]Co-Chair of Sarcoma Patients EuroNet (SPAEN), Woelfersheim, Germany & Chairman of
the Dutch organisation for sarcoma patients (Patiëntenplatform Sarcomen), Guest researcher
at Leiden University (Leiden Institute for Advanced Computer Science), Leiden University,
Leiden, The Netherlands
[83
]Chair of the Board of Directors of Sarcoma Patients EuroNet (SPAEN), Sarcoma Patients
EuroNet (SPAEN), Woelfersheim, Germany
[84
]The Royal Marsden NHS Foundation Trust, London, UK
[85
]Molecular Pharmacology Unit, Department of Applied Research and Technological Development,
Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
[86
]Department of Supportive Care, Princess Margaret Cancer Centre and Division of Palliative
Medicine, Department of Medicine, University of Toronto, Toronto, Canada
